The proresilients in multimodal programmes for the prevention of premature ageing by Rubikas, V. et al.
Мини-обзор 
Mini-review 
Rubikas V, et al. The proresilients in multimodal programmes … 397 
КЛИНИЧЕСКАЯ МЕДИЦИНА  
MEDICINE 
DOI: 10.18413/2658-6533-2020-6-3-0-9  UDC 612.67 
The proresilients in multimodal programmes 












3 Universiteto St., Vilnius, 01513, Lithuania 
Corresponding author: Tatsiana Piatryshcha (longtermcare.fmba@gmail.com) 
Abstract 
Background: Premature ageing is a common process. According to various authors, 
at least 10-20% of middle-aged people have unfavorable levels of discrepancy be-
tween biological and passport age. That is why the preventive direction is actively 
developing in gerontology. Various substances like the proresilients, for example, are 
actively studied for their geroprotective properties in terms of their impact on cellular 
mechanisms of premature ageing. The aim of the study: To study the properties of 
the proresilients in multimodal programs for the prevention of premature ageing. 
Materials and methods: We studied literary figures for 2015-2020 in computer da-
tabases, PubMed, Medical-Science, Elibrary, Ceeol, JSTOR, Web of Science, Sco-
pus. Results: The proresilients are used in various programs for improving the body 
and reducing the aging process of cells, reducing oxidative stress and other patholog-
ical mechanisms. They act at the level of the cell so they can slow down the destruc-
tion of organs and balance systems. This is due to their positive effect on the entire 
body and the patient's well-being. The proresilients have the criteria of a good phar-
maceutical practices and quality criteria of 4G. The application of the proresilients is 
important in three areas of medicine like cosmetology, anti-ageing and preventive 
medicine. Age-related skin changes are inevitable, but it is important to take 
measures to prevent premature ageing. That‘s why it`s important to use the proresili-
ents to prevent skin changes and premature ageing. Conclusion: In conclusion, the 
proresilients is a new, actively developed group of nutraceutical drugs that can be 
successfully used in modern health management technologies in multi-modal preven-
tion and rehabilitation programs. 
Keywords: proresilients; age changes; age; multimodal programmes 
For citation: Rubikas V, Piatryshcha T, Rozhdestvenskaya O, et al. The proresilients 
in multimodal programmes for the prevention of premature ageing. Research Results 
in Biomedicine. 2020;6(3):397-401. DOI: 10.18413/2658-6533-2020-6-3-0-9 
Мини-обзор 
Mini-review 
Научные результаты биомедицинских исследований. 2020;6(3):397-401 
Research Results in Biomedicine. 2020;6(3):397-407 
398 
Introduction. Premature ageing is a 
common process. According to various au-
thors, at least 10-20% of middle-aged people 
have unfavorable levels of discrepancy be-
tween biological and chronical age [1, 2].  
The factor of polymorbidity, that is, the 
presence of a large number of age-associated 
diseases in one organism, leads to the devel-
opment of premature aging syndrome and 
premature wear of organs and systems. Deple-
tion of vital resources of the organism can 
also be a trigger for the development of these 
diseases. This is also an independent cause of 
the development of premature aging syn-
drome [3].  
In this regard, preventive medicine has 
been developing more and more in the world. 
Currently, we are searching for substances 
and drugs to protect cells from aging, those 
that have chronoprotective and geroprotective 
actions and act at the cell level. These drugs 
include the proresilients [1, 4]. 
To implement the principles of preven-
tive geriatrics, complex basic therapy should 
be supplemented with the application of the 
proresilients to level the processes of prema-
ture ageing. Thus, it is important to study the 
preparations of the proresilients in multimodal 
programs for the prevention of premature age-
ing [1, 3, 4]. 
The purpose of this research is to 
study the properties of the proresilients in 
multimodal programs for the prevention of 
premature ageing.   
Materials and methods of research. 
We studied literary figures for 2015-2020 in 
computer databases, PubMed, Medical-
Science, Elibrary, Ceeol, JSTOR, Web of 
Science, Scopus. 
Results and discussion. Medical and 
biological sciences are searching for sub-
stances that have the properties of preventing 
the development of premature aging syn-
drome. The proresilients is a class of sub-
stances which inhibit the process of premature 
ageing at the cellular level [1, 4, 5].  
The proresilients are used in various 
programs for improving the body and reduc-
ing the aging process of cells, reducing oxida-
tive stress and other pathological mecha-
nisms. They act at the level of the cell so they 
can slow down the destruction of organs and 
balance systems. This is due to their positive 
effect on the entire body and the patient's 
well-being [1, 4]. 
The proresilients have the criteria of a 
good pharmaceutical practices and quality 
criteria of 4G [4]. 
The proresilients are a substance (com-
pound) that has experimentally and clinically 
proven effectiveness in preventing premature 
ageing, which have geroprotective preventive 
activity. They are most effective at the age of 
35 years and older [1, 4]. 
The proresilients can affect the process-
es of oxidative stress, chronic intoxication in 
the form of chronic information exhaustion, 
the development of chronic fatigue, daily lead 
poisoning with minimal doses, alcohol or 
smoking. 
We also use the term a bioregulatory 
nutraceutical drug – a drug for prevention and 
rehabilitation, which includes one or more 
proresilients, which are natural components of 
food and medicinal plants [1, 3, 4]. 
Natural proresilients are normally con-
sumed with food. Life in the modern world 
involves poor nutrition; frequent use of re-
strictive diets leads to a lack of nutrients [6]. 
In fact, the main geroprotector is food, 
primarily due to the natural antioxidants con-
tained in food and other compounds necessary 
for the normal maintenance of basic life func-
tions. For example, regular consumption of 
foods with a high content of flavonoids (ber-
ries, coconut, tea, etc.) may contribute to the 
maintenance of cognitive abilities due to their 
participation in the regulation of cerebral 
blood flow, reducing damage to neurons by 
neurotoxins and circulating inflammatory cy-
tokines. For example, dietary factors are im-
portant modifiable risk factors for coronary 
heart disease. Nutrients (beta-carotene, B9 
(folic acid), fiber, vitamins A, B, C, etc.) are 
useful for the prevention of cardiovascular 
diseases [7]. 
There is increasing evidence that natural 
proresilients and herbal preparations have an-
tioxidant, anti-inflammatory and antiamyloid 
properties. They are able to regulate mito-
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chondrial stress, the activity of antioxidant 
systems, the activity of neurotrophic factors, 
apoptosis factors, that is, to influence the 
main mechanisms of cell ageing [1, 4, 8]. 
Some researchers are also interested in 
medicines, food and some plants as a poten-
tial source of the proresilients. The applica-
tion of medicinal plants in gerontology is par-
ticularly relevant. The active substances inter-
fere in the metabolism of an ageing body, 
change the immune system, purify all organs 
at the cellular level, have a restorative effect, 
and contribute to the preservation and im-
proving health. The advantages of herbal 
medicines include a combination of effective-
ness and high safety, polyfunctionality and 
softness of their pharmacological action, low 
toxicity and lack of drug dependence [9].  
Currently, the proresilients are being 
developed in the Autonomous Non-profit Or-
ganization «Research Medical Center "Geron-
tology" (http://www.gerontolog.info) for sci-
entific generalization of new achievements in 
the field of gerontology, geriatrics and anti-
ageing medicine. The specialists of the Center 
have created new drugs for improving the 
profile of ageing and preventing premature 
ageing syndrome.  
The proresilients and bioregulating 
nutraceutical preparations consist of amino 
acids, vitamins, mineral compounds and other 
components necessary for the organism after 
constant stress, chronic diseases and prema-
ture ageing syndrome. They can improve the 
quality of multimodal prevention and rehabili-
tation programs for patients and improve the 
quality of people‘s lives of different ages. The 
main proresilients are Energoton, MCM, Car-
dioton, Beta-alanine, Memoton, Proderma, C2 
and others [1, 4].  
The application of the proresilients is 
important in three areas of medicine like cos-
metology, anti-ageing and preventive medi-
cine [1, 4, 10].  
Age-related changes in the skin begin at 
the age of 25: regeneration slows down, fibers 
thin, and elasticity decreases. The violation of 
circulation leads to a decrease in metabolic 
processes in the upper layer of the epidermis, 
a shortage of necessary trace elements and 
substances. The muscle tissue also undergoes 
changes: the mimic constriction increases, 
while its tone decreases, which leads to the 
formation of wrinkles. There is also a tenden-
cy to hyperpigmentation with age, there is a 
redistribution of subcutaneous fat in the face, 
which leads to sagging of the cheeks and eyes 
[1, 4, 11].    
Hormonal changes in the body can be 
also observed after the age of 30, namely, the 
production of estrogen decreases, which leads 
to increased dryness of the skin and mucous 
membranes, a decrease in the amount of mu-
copolysaccharides, and the appearance of tel-
angiectasias [12]. 
Age-related skin changes are inevitable. 
These include: exclusion of bad habits, reduc-
ing the influence of oxidative stress, nutri-
tional support, and others. That‘s why it`s im-
portant to use the proresilients to prevent skin 
changes and premature ageing [4, 13]. 
In cosmetology we use the proresilients 
in the main cosmetic procedures like surface 
peels, biorevitalization, bioreparation, botuli-
num toxin therapy, thread lifting, laser re-
moval of vessels and others. 
In anti-age medicine we use the prore-
silients in comprehensive prevention and re-
habilitation of persons with benign age-
related forgetfulness, complex management of 
age-related hand and foot syndromes, correc-
tion of age-related dry skin, multimodal reha-
bilitation of persons with age-related andro-
gen deficiency, pronounced vegetative mani-
festations, with climacteric syndrome with 
pronounced vegetative manifestations, age-
associated malnutrition syndrome, compre-
hensive prevention of osteoarthrosarcopenia, 
rehabilitation for chronic information exhaus-
tion and chronic asthenia syndrome, compre-
hensive case management of persons with 
premature ageing syndrome [1, 4]. 
In preventive medicine we use the pro-
resilients in seasonal immunomodulation 
(with seasonal increases in the incidence of 
acute viral respiratory infections), bionutri-
tional support in the presence of acute respira-
tory viral infections, maintenance of a com-
prehensive prevention of atherosclerosis, 
complex prevention of enthesopathies and 
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arthritis against the background of starting 
classes in health-improving physical culture, 
integrated hepatoprotective, the support of 
persons with syndromes of dependence on 
psychoactive substances (nicotine, alcohol), 
support for restrictive diets, including the pe-
riods during religious dietary restrictions, a 
complex therapy of sleep disorders, with emo-
tional and physical overload, a complex ther-
apy of allergoses, including atopic dermatitis 
and others [1, 4, 14]. 
Conclusion.  In conclusion, the pro-
resilients is a new, actively developed group 
of nutraceutical drugs that can be successfully 
used in modern health management technolo-
gies in multi-modal prevention and rehabilita-
tion programs. 
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